How big is Blueprint Medicines Corp.?

Jun 22 2025 06:04 PM IST
share
Share Via
As of Jun 18, Blueprint Medicines Corp. has a market capitalization of $8.29 billion, with net sales of $562.12 million and a net profit of -$155.73 million over the latest four quarters. Shareholder's funds are $298.67 million, and total assets amount to $1.18 billion.
As of Jun 18, Blueprint Medicines Corp. has a market capitalization of 8,292.13 million, categorizing it as a Mid Cap company.

As of Jun 18, the company reported net sales of 562.12 million for the latest four quarters, while the net profit for the same period was -155.73 million.

As of Dec 24, the reporting period shows shareholder's funds of 298.67 million and total assets amounting to 1,179.81 million.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Is Blueprint Medicines Corp. overvalued or undervalued?
Sep 20 2025 06:26 PM IST
share
Share Via
Is Blueprint Medicines Corp. overvalued or undervalued?
Jun 25 2025 09:04 AM IST
share
Share Via
What does Blueprint Medicines Corp. do?
Jun 22 2025 06:48 PM IST
share
Share Via